Bioteque Corporation (4107.TWO)
TWD 120.0
(-1.23%)
TWD 120.0
(-1.23%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 452.55 Million TWD | -8.31% |
| 2022 | 493.54 Million TWD | 14.44% |
| 2021 | 431.25 Million TWD | -11.75% |
| 2020 | 488.66 Million TWD | 5.28% |
| 2019 | 464.17 Million TWD | 14.61% |
| 2018 | 404.99 Million TWD | 33.25% |
| 2017 | 303.93 Million TWD | -15.16% |
| 2016 | 358.23 Million TWD | 13.45% |
| 2015 | 315.76 Million TWD | 8.55% |
| 2014 | 290.9 Million TWD | 35.16% |
| 2013 | 215.22 Million TWD | 29.41% |
| 2012 | 166.3 Million TWD | 29.32% |
| 2011 | 128.59 Million TWD | -25.49% |
| 2010 | 172.58 Million TWD | 8.88% |
| 2009 | 158.51 Million TWD | -7.55% |
| 2008 | 171.45 Million TWD | -44.54% |
| 2007 | 309.14 Million TWD | 439.83% |
| 2006 | 57.26 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 124.52 Million TWD | -0.93% |
| 2024 Q1 | 125.68 Million TWD | 19.49% |
| 2023 Q1 | 98.69 Million TWD | -13.02% |
| 2023 Q2 | 102.58 Million TWD | 3.94% |
| 2023 FY | 452.55 Million TWD | -8.31% |
| 2023 Q4 | 105.18 Million TWD | -27.99% |
| 2023 Q3 | 146.08 Million TWD | 42.4% |
| 2022 Q2 | 124.11 Million TWD | 1.67% |
| 2022 Q4 | 113.47 Million TWD | -15.22% |
| 2022 Q1 | 122.08 Million TWD | -6.54% |
| 2022 FY | 493.54 Million TWD | 14.44% |
| 2022 Q3 | 133.85 Million TWD | 7.84% |
| 2021 Q4 | 130.62 Million TWD | 46.04% |
| 2021 Q1 | 120.5 Million TWD | -19.98% |
| 2021 FY | 431.25 Million TWD | -11.75% |
| 2021 Q2 | 90.68 Million TWD | -24.75% |
| 2021 Q3 | 89.44 Million TWD | -1.37% |
| 2020 FY | 488.66 Million TWD | 5.28% |
| 2020 Q1 | 108.54 Million TWD | 5.42% |
| 2020 Q4 | 150.59 Million TWD | 24.02% |
| 2020 Q3 | 121.42 Million TWD | 12.33% |
| 2020 Q2 | 108.09 Million TWD | -0.41% |
| 2019 FY | 464.17 Million TWD | 14.61% |
| 2019 Q2 | 131.5 Million TWD | 13.37% |
| 2019 Q1 | 115.99 Million TWD | 0.76% |
| 2019 Q4 | 102.96 Million TWD | -9.45% |
| 2019 Q3 | 113.7 Million TWD | -13.54% |
| 2018 FY | 404.99 Million TWD | 33.25% |
| 2018 Q3 | 93.72 Million TWD | -17.26% |
| 2018 Q4 | 115.12 Million TWD | 22.83% |
| 2018 Q1 | 82.87 Million TWD | -9.92% |
| 2018 Q2 | 113.27 Million TWD | 36.69% |
| 2017 Q4 | 92 Million TWD | -0.31% |
| 2017 Q1 | 48.24 Million TWD | -43.37% |
| 2017 Q3 | 92.29 Million TWD | 29.26% |
| 2017 FY | 303.93 Million TWD | -15.16% |
| 2017 Q2 | 71.4 Million TWD | 47.99% |
| 2016 Q2 | 100.67 Million TWD | 9.95% |
| 2016 Q3 | 80.79 Million TWD | -19.74% |
| 2016 Q4 | 85.2 Million TWD | 5.45% |
| 2016 FY | 358.23 Million TWD | 13.45% |
| 2016 Q1 | 91.56 Million TWD | 39.06% |
| 2015 FY | 315.76 Million TWD | 8.55% |
| 2015 Q1 | 71.57 Million TWD | -12.37% |
| 2015 Q4 | 65.84 Million TWD | -35.15% |
| 2015 Q2 | 76.81 Million TWD | 7.32% |
| 2015 Q3 | 101.53 Million TWD | 32.18% |
| 2014 Q4 | 81.67 Million TWD | 8.63% |
| 2014 FY | 290.9 Million TWD | 35.16% |
| 2014 Q3 | 75.18 Million TWD | 4.66% |
| 2014 Q2 | 71.83 Million TWD | 15.5% |
| 2014 Q1 | 62.19 Million TWD | 17.29% |
| 2013 Q4 | 53.02 Million TWD | -8.63% |
| 2013 FY | 215.22 Million TWD | 29.41% |
| 2013 Q1 | 48.24 Million TWD | -5.18% |
| 2013 Q2 | 55.91 Million TWD | 15.9% |
| 2013 Q3 | 58.03 Million TWD | 3.8% |
| 2012 Q2 | 33.9 Million TWD | -8.28% |
| 2012 Q1 | 36.96 Million TWD | -28.2% |
| 2012 Q3 | 44.71 Million TWD | 31.91% |
| 2012 FY | 166.3 Million TWD | 29.32% |
| 2012 Q4 | 50.87 Million TWD | 13.77% |
| 2011 Q2 | 29.52 Million TWD | 10.17% |
| 2011 Q1 | 26.79 Million TWD | -18.91% |
| 2011 FY | 128.59 Million TWD | -25.49% |
| 2011 Q3 | 20.8 Million TWD | -29.52% |
| 2011 Q4 | 51.47 Million TWD | 147.43% |
| 2010 Q4 | 33.04 Million TWD | -29.8% |
| 2010 Q3 | 47.06 Million TWD | -9.65% |
| 2010 Q2 | 52.09 Million TWD | 29.0% |
| 2010 Q1 | 40.38 Million TWD | 0.0% |
| 2010 FY | 172.58 Million TWD | 8.88% |
| 2009 FY | 158.51 Million TWD | -7.55% |
| 2008 FY | 171.45 Million TWD | -44.54% |
| 2007 FY | 309.14 Million TWD | 439.83% |
| 2006 FY | 57.26 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 545.95 Million TWD | 17.108% |
| Chi Sheng Pharma & Biotech Co., Ltd | 68.67 Million TWD | -558.983% |
| Sunder Biomedical Tech. Co., Ltd. | -33.15 Million TWD | 1464.952% |
| BenQ Medical Technology Corporation | 114.58 Million TWD | -294.961% |
| Pacific Hospital Supply Co., Ltd | 420.79 Million TWD | -7.547% |
| Unicon Optical Co., Ltd. | 207.73 Million TWD | -117.847% |
| Formosa Optical Technology Co.,Ltd. | 417.94 Million TWD | -8.281% |
| Medeon Biodesign, Inc. | -1.2 Billion TWD | 137.568% |
| Concord Medical Co., Ltd. | 42.74 Million TWD | -958.745% |
| Crystalvue Medical Corporation | 103.39 Million TWD | -337.686% |
| Perfect Medical Industry Co., Ltd. | 40.08 Million TWD | -1028.863% |
| ICARES Medicus, Inc. | 97.72 Million TWD | -363.066% |
| Lagis Enterprise Co., Ltd. | 64.1 Million TWD | -605.951% |
| Amed Co., Ltd. | 91.71 Million TWD | -393.425% |